A Lupus (SLE) programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €18,400–€46,000 in the United States. About 11.5h from New York, inside the EU, visa-free.
If you are researching Lupus (SLE) treatment from the United States, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €18,400–€46,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
Lupus (systemic lupus erythematosus, SLE) is an autoimmune disease in which the body's immune system mistakenly attacks its own tissues, particularly affecting joints, skin, kidneys, and the nervous system. The condition arises when B cells and T cells lose tolerance to self-antigens, producing damaging antibodies and inflammatory cytokines. Placental mesenchymal stem cells show promise because they release immunomodulatory factors—interleukins, soluble HLA-G, and exosomes containing regulatory microRNAs—that rebalance Th17 and regulatory T-cell populations. Early-stage clinical research (47 registered trials, 6 currently recruiting) suggests this approach may reduce disease activity scores and improve organ function in selected patients, though long-term remission rates remain under investigation. It is delivered under a physician-led protocol and designed to complement your existing care.
| United States (home) | Stem Plus · EU | |
|---|---|---|
| Lupus (SLE) treatment | €18,400–€46,000 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 11.5h from New York | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
طب تجديدي معتمد GMP في قلب الاتحاد الأوروبي — من 3,000 إلى 8,000 يورو، جزء بسيط من أسعار أمريكا أو ألمانيا. بروتوكولات مخصصة لمرضى من أكثر من 50 دولة.
مراجعة طبية مجانية